On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction
From MaRDI portal
(Redirected from Publication:544613)
Recommendations
- A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
- Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
- Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
- Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
- A new method for recognition proteomic mass spectrometry data using double-time projections
Cites work
- scientific article; zbMATH DE number 3483405 (Why is no real title available?)
- scientific article; zbMATH DE number 1461524 (Why is no real title available?)
- Classifier technology and the illusion of progress
- Downdating: Interdisciplinary Research Between Statistics and Computing
- Exact Principal Component Influence Measures Applied to the Analysis of Spectroscopic Data on Rice
- Organizing a competition on clinical mass spectrometry based proteomic diagnosis
- Random forests
- Stacked regressions
- Two further applications of a model for binary regression
Cited in
(3)- Sequential double cross-validation for assessment of added predictive ability in high-dimensional omic applications
- A new method for recognition proteomic mass spectrometry data using double-time projections
- A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
This page was built for publication: On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q544613)